drugset / Trial / NCT04599062
TVEC and Preop Radiation for Sarcoma (8 ml Dose)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this research study is to determine the safety and tolerability of talimogene laherparepvec when combined with radiation therapy. Approximately 46 people will take part in this study conducted by investigators at the University of Iowa.
Timeline
- Start
- 2020-09-10
- Primary completion
- 2023-02-07
- Completion
- 2028-02-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Talimogene Laherparepvec | Other / unclassified | 8 ml | Other |